CA2786329A1 - Anti - infective pyrido (1,2-a) pyrimidines - Google Patents
Anti - infective pyrido (1,2-a) pyrimidines Download PDFInfo
- Publication number
- CA2786329A1 CA2786329A1 CA2786329A CA2786329A CA2786329A1 CA 2786329 A1 CA2786329 A1 CA 2786329A1 CA 2786329 A CA2786329 A CA 2786329A CA 2786329 A CA2786329 A CA 2786329A CA 2786329 A1 CA2786329 A1 CA 2786329A1
- Authority
- CA
- Canada
- Prior art keywords
- nmr
- mhz
- cdc13
- pyrido
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29455210P | 2010-01-13 | 2010-01-13 | |
US61/294,552 | 2010-01-13 | ||
PCT/EP2011/000135 WO2011085990A1 (en) | 2010-01-13 | 2011-01-13 | Anti - infective pyrido (1,2 -a) pyrimidines |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2786329A1 true CA2786329A1 (en) | 2011-07-21 |
Family
ID=43610218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2786329A Abandoned CA2786329A1 (en) | 2010-01-13 | 2011-01-13 | Anti - infective pyrido (1,2-a) pyrimidines |
Country Status (9)
Country | Link |
---|---|
US (1) | US20130012506A1 (pt-PT) |
EP (1) | EP2523956A1 (pt-PT) |
JP (1) | JP2013517233A (pt-PT) |
KR (1) | KR20130088002A (pt-PT) |
CN (1) | CN102812023A (pt-PT) |
AU (1) | AU2011206761A1 (pt-PT) |
BR (1) | BR112012017473A2 (pt-PT) |
CA (1) | CA2786329A1 (pt-PT) |
WO (1) | WO2011085990A1 (pt-PT) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014019750B1 (pt) * | 2012-02-10 | 2020-03-03 | F. Hoffmann-La Roche Ag. | Composto, composição farmacêutica e seus usos |
JP6092264B2 (ja) | 2012-03-01 | 2017-03-08 | ピーティーシー セラピューティクス, インコーポレイテッド | 脊髄性筋委縮症を処置するための化合物 |
CA2868026C (en) | 2012-03-23 | 2021-02-16 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
EP3082820B1 (en) | 2013-12-19 | 2022-07-20 | PTC Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
EP3227292B1 (en) * | 2014-12-02 | 2022-03-09 | Alterity Therapeutics Limited | 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS |
US10668171B2 (en) | 2015-05-30 | 2020-06-02 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
CN105153151A (zh) * | 2015-08-28 | 2015-12-16 | 张文莲 | 一种嘧啶酮类化合物的合成方法 |
WO2017100726A1 (en) | 2015-12-10 | 2017-06-15 | Ptc Therapeutics, Inc. | Methods for treatng huntington's disease |
EP3544435A4 (en) | 2016-11-28 | 2020-11-04 | PTC Therapeutics, Inc. | RNA SPLICE MODULATION PROCESSES |
AU2018282154B2 (en) | 2017-06-05 | 2022-04-07 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
WO2018232039A1 (en) | 2017-06-14 | 2018-12-20 | Ptc Therapeutics, Inc. | Methods for modifying rna splicing |
CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
WO2019005980A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
SG11202009212WA (en) | 2018-03-27 | 2020-10-29 | Ptc Therapeutics Inc | Compounds for treating huntington's disease |
EP3814360A1 (en) | 2018-06-27 | 2021-05-05 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
KR20210042265A (ko) | 2018-06-27 | 2021-04-19 | 피티씨 테라퓨틱스, 인크. | 헌팅턴병 치료를 위한 헤테로사이클릭 및 헤테로아릴 화합물 |
CN114106000B (zh) * | 2021-12-15 | 2023-11-24 | 中国科学院新疆理化技术研究所 | 一种咪唑并[4,5-d]嘧啶酮三环类衍生物及抗肿瘤用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4603044A (en) | 1983-01-06 | 1986-07-29 | Technology Unlimited, Inc. | Hepatocyte Directed Vesicle delivery system |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US4957773A (en) | 1989-02-13 | 1990-09-18 | Syracuse University | Deposition of boron-containing films from decaborane |
WO2001058876A1 (fr) * | 2000-02-09 | 2001-08-16 | Daiichi Pharmaceutical Co., Ltd. | Agents antibacteriens acidoresistants renfermant des acides pyridonecarboxyliques comme principe actif |
CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
CN102105470B (zh) * | 2008-06-17 | 2014-06-04 | 韩国巴斯德研究所 | 作为抗结核病药的吡啶并嘧啶化合物 |
WO2010001366A1 (en) * | 2008-07-04 | 2010-01-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Piperazines derivatives as proteasome modulators |
-
2011
- 2011-01-13 AU AU2011206761A patent/AU2011206761A1/en not_active Abandoned
- 2011-01-13 KR KR1020127018472A patent/KR20130088002A/ko not_active Application Discontinuation
- 2011-01-13 US US13/518,292 patent/US20130012506A1/en not_active Abandoned
- 2011-01-13 CN CN2011800059743A patent/CN102812023A/zh active Pending
- 2011-01-13 JP JP2012548380A patent/JP2013517233A/ja not_active Withdrawn
- 2011-01-13 BR BR112012017473A patent/BR112012017473A2/pt not_active IP Right Cessation
- 2011-01-13 EP EP11700392A patent/EP2523956A1/en not_active Withdrawn
- 2011-01-13 WO PCT/EP2011/000135 patent/WO2011085990A1/en active Application Filing
- 2011-01-13 CA CA2786329A patent/CA2786329A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2011085990A8 (en) | 2012-10-26 |
WO2011085990A1 (en) | 2011-07-21 |
KR20130088002A (ko) | 2013-08-07 |
CN102812023A (zh) | 2012-12-05 |
EP2523956A1 (en) | 2012-11-21 |
AU2011206761A1 (en) | 2012-07-12 |
US20130012506A1 (en) | 2013-01-10 |
JP2013517233A (ja) | 2013-05-16 |
BR112012017473A2 (pt) | 2019-09-24 |
AU2011206761A2 (en) | 2012-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2786329A1 (en) | Anti - infective pyrido (1,2-a) pyrimidines | |
EP2310388B1 (en) | Pyridopyrimidine compounds as anti-tubercular agents | |
KR101732212B1 (ko) | 항감염성 화합물 | |
CA2632476A1 (en) | Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents | |
US20140107106A1 (en) | Therapeutic agents, and methods of making and using the same | |
US20100317607A1 (en) | Use of compounds for preparing anti-tuberculosis agents | |
CA2658506A1 (en) | Acrylamide derivatives as fab 1 inhibitors | |
CA2800618A1 (en) | Heteroaryl compounds and methods of use thereof | |
CN102781940A (zh) | 取代的咪唑并吡啶基-氨基吡啶化合物 | |
AU2022228101A1 (en) | Sulfone pyridine alkyl amide-substituted heteroaryl compounds | |
CA3141905A1 (en) | Bicyclic derivatives for treating endoparasites | |
CA3204171A1 (en) | Bicyclic derivatives | |
JP2006517976A (ja) | 新規化合物 | |
US20070232640A1 (en) | Antifungal and antiparasitic indoloquinoline derivates | |
Vekariya et al. | Synthesis of pyrazolo [4ʹ, 3ʹ: 5, 6] pyrano [2, 3-d] pyrimidine derivatives and their antimicrobial, antimalarial and antituberculosis evaluation | |
JP2015500295A (ja) | ヒト結核菌を標的とする医薬としてのベンゾトリアジンオキサイド類 | |
CA3204133A1 (en) | Indole derivatives as kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |
Effective date: 20150113 |